290 related articles for article (PubMed ID: 17608637)
1. Estimates and projections of hepatitis B-related hepatocellular carcinoma in Australia among people born in Asia-Pacific countries.
Nguyen VT; Razali K; Amin J; Law MG; Dore GJ
J Gastroenterol Hepatol; 2008 Jun; 23(6):922-9. PubMed ID: 17608637
[TBL] [Abstract][Full Text] [Related]
2. Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, Australia.
Nguyen VT; Amin J; Law MG; Dore GJ
J Gastroenterol Hepatol; 2009 Mar; 24(3):436-42. PubMed ID: 19175834
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma.
Kew MC
Pathol Biol (Paris); 2010 Aug; 58(4):273-7. PubMed ID: 20378277
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden.
Nguyen VT; Law MG; Dore GJ
J Viral Hepat; 2009 Jul; 16(7):453-63. PubMed ID: 19302335
[TBL] [Abstract][Full Text] [Related]
5. Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan.
Tseng TC; Liu CJ; Chen PJ; Lai MY; Lin CL; Kao JH; Chen DS
Liver Int; 2007 Sep; 27(7):983-8. PubMed ID: 17696938
[TBL] [Abstract][Full Text] [Related]
6. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma
J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
[TBL] [Abstract][Full Text] [Related]
7. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
[TBL] [Abstract][Full Text] [Related]
8. [Hepatocellular carcinoma: rising incidence of hepatitis C virus-associated cases at a university clinic in Germany].
Erhardt A; Theobald I; Petry W; Röhrborn A; Heintges T; Wettstein M; Häussinger D
Dtsch Med Wochenschr; 2002 Dec; 127(50):2665-8. PubMed ID: 12481236
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma in an Australian tertiary referral hospital 1975-2002: change in epidemiology and clinical presentation.
Roberts SK; Kemp W
J Gastroenterol Hepatol; 2007 Feb; 22(2):191-6. PubMed ID: 17295870
[TBL] [Abstract][Full Text] [Related]
11. High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma.
Chan HL; Tse CH; Mo F; Koh J; Wong VW; Wong GL; Lam Chan S; Yeo W; Sung JJ; Mok TS
J Clin Oncol; 2008 Jan; 26(2):177-82. PubMed ID: 18182659
[TBL] [Abstract][Full Text] [Related]
12. Chronic hepatitis B and hepatocellular carcinoma.
McClune AC; Tong MJ
Clin Liver Dis; 2010 Aug; 14(3):461-76. PubMed ID: 20638025
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or C.
Walter SR; Thein HH; Gidding HF; Amin J; Law MG; George J; Dore GJ
J Gastroenterol Hepatol; 2011 Dec; 26(12):1757-64. PubMed ID: 21615789
[TBL] [Abstract][Full Text] [Related]
14. Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta-analysis.
Shi Y; Wu YH; Wu W; Zhang WJ; Yang J; Chen Z
Liver Int; 2012 Feb; 32(2):231-40. PubMed ID: 21745272
[TBL] [Abstract][Full Text] [Related]
15. Anticardiolipin antibodies in chronic hepatitis B and chronic hepatitis D infection, and hepatitis B-related hepatocellular carcinoma. Relationship with portal vein thrombosis.
Elefsiniotis IS; Diamantis ID; Dourakis SP; Kafiri G; Pantazis K; Mavrogiannis C
Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):721-6. PubMed ID: 12811301
[TBL] [Abstract][Full Text] [Related]
16. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.
Yin J; Zhang H; Li C; Gao C; He Y; Zhai Y; Zhang P; Xu L; Tan X; Chen J; Cheng S; Schaefer S; Cao G
Carcinogenesis; 2008 Sep; 29(9):1685-91. PubMed ID: 18192693
[TBL] [Abstract][Full Text] [Related]
17. Infection with hepatitis B and C viruses, social class and cancer.
Stuver SO; Boschi-Pinto C; Trichopoulos D
IARC Sci Publ; 1997; (138):319-24. PubMed ID: 9353672
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of hepatitis B virus infection among the tribes of Andaman and Nicobar Islands, India.
Murhekar MV; Murhekar KM; Sehgal SC
Trans R Soc Trop Med Hyg; 2008 Aug; 102(8):729-34. PubMed ID: 18565560
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
Shrestha SM; Shrestha S; Shrestha A; Tsuda F; Endo K; Takahashi M; Okamoto H
J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971
[TBL] [Abstract][Full Text] [Related]
20. Risk assessment for hepatocellular carcinoma in chronic hepatitis B: scores and surveillance.
Gonzalez SA; Keeffe EB
Int J Clin Pract; 2012 Jan; 66(1):7-10. PubMed ID: 22171899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]